Covered recipient · General Payments record
VIVEK RAO NADIPALLI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$937.91
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $739.90 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $269.89 | 3 |
| Amgen Inc. | $243.36 | 5 |
| E.R. Squibb & Sons, L.L.C. | $190.47 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $36.18 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $82.06 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115955971 | CMS |
| Amgen Inc. | $15.35 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117637495 | CMS |
| Amgen Inc. | $73.17 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117637497 | CMS |
| Amgen Inc. | $27.10 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117637499 | CMS |
| Amgen Inc. | $45.68 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117637501 | CMS |
| AstraZeneca Pharmaceuticals LP | $117.97 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110515472 | CMS |
| AstraZeneca Pharmaceuticals LP | $44.79 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110511562 | CMS |
| AstraZeneca Pharmaceuticals LP | $107.13 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110511506 | CMS |
| Boston Scientific Corporation | $4.98 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092231884 | CMS |
| Boston Scientific Corporation | $31.20 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092231886 | CMS |
| E.R. Squibb & Sons, L.L.C. | $93.63 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101408895 | CMS |
| E.R. Squibb & Sons, L.L.C. | $96.84 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101408913 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.